ESR1 and breast cancer: Moreover, we hypothesized that breast cancers harboring an ESR1 mutation may show a different recurrence pattern compared to those with wild-type ESR1. We further addressed the relationship between the presence of an ESR1 mutation and primary endocrine resistance in patients receiving adjuvant ET.